Showing results (501-510 of 615) with videos related to

Sort By:
Pageof 62
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 8, 2016
Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-netPetra Steinacker, André Huss, Benjamin Mayer, et al.
Annals of Neurology|January 6, 2004
Chromosomal translocation t(18;21)(q23;q22.1) indicates novel susceptibility loci for frontotemporal dementia with ALSJohannes Prudlo, Burkhard Alber, Vera M Kalscheuer, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 5, 2025
[Point-of-care tests for sexually transmitted infections-what is the current status?]Viviane Bremer, Heinrich Scheiblauer, Maximilian Muenchhoff, et al.
Der Nervenarzt|January 9, 2019
[Treatment evaluation in patients with 5q-associated spinal muscular atrophy : Real-world experience]Maggie C Walter, Bianca Dräger, Rene Günther, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 26, 2014
Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer: results of the first prospective randomized phase II trialHenriette Golcher, Thomas B Brunner, Helmut Witzigmann, et al.
Journal of the Neurological Sciences|July 13, 2005
Spastin related hereditary spastic paraplegia with dysplastic corpus callosumBurkhard Alber, Magdalena Pernauer, Annemarie Schwan, et al.
American Journal of Human Genetics|April 28, 2006
Breakpoint cloning and haplotype analysis indicate a single origin of the common Inv(10)(p11.2q21.2) mutation among northern EuropeansMette Gilling, Jörn S Dullinger, Stefan Gesk, et al.
JAMA Neurology|December 2, 2014
Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment responseFrank Leypoldt, Romana Höftberger, Maarten J Titulaer, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|July 12, 2002
A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase CAndres Virchis, Kanagasabai Ganeshaguru, Steve Hart, et al.
Pageof 62